We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $109M
1-Year Est. Return 97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$6.53M
Cap. Flow
-$6.26M
Cap. Flow %
-5.72%
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29

Top Buys

Rank Stock Value
1
NOMD icon
Nomad Foods
NOMD
+$1.34M
2
MLAA
Mountain Lake Acquisition Corp II
MLAA
+$1.27M
3
DSGR icon
Distribution Solutions Group
DSGR
+$1.26M
4
ENGN icon
enGene Therapeutics
ENGN
+$1.24M
5
ABVX
Abivax
ABVX
+$1.02M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$8.47M
2
LEG
Leggett & Platt
LEG
+$2.1M
3
ICLR icon
Icon
ICLR
+$1.96M
4
KZR
Kezar Life Sciences
KZR
+$1.8M
5
MCW
Mister Car Wash
MCW
+$1.54M

Sector Composition

Rank Sector Weight
1 Healthcare 27.11%
2 Consumer Discretionary 14.33%
3 Financials 12.51%
4 Miscellaneous 10.11%
5 Real Estate 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZLT icon
151
Rezolute
RZLT
$397M
$102K 0.09%
19,650
-20,350
-51% -$75.6K
DDL
152
Dingdong
DDL
$466M
$96.5K 0.09%
50,000
– –
ABOS icon
153
Acumen Pharmaceuticals
ABOS
$206M
$93.5K 0.09%
35,000
– –
GTM
154
ZoomInfo Technologies
GTM
$1.11B
$87.9K 0.08%
+30,000
New +$135K
CYCN
155
DELISTED
Cyclerion Therapeutics
CYCN
$82.4K 0.08%
+24,310
New +$78.9K
YARW
156
Yarrow Bioscience
YARW
$71.4M
$73.6K 0.07%
2,261
-100
-4% -$3.24K
GRCE
157
Grace Therapeutics
GRCE
$47.3M
$59K 0.05%
+26,000
New +$71.9K
SOC icon
158
Sable Offshore Corp
SOC
$938M
$58.5K 0.05%
19,000
– –
SITC icon
159
SITE Centers
SITC
$147M
$55.6K 0.05%
14,000
– –
GECC icon
160
Great Elm Capital Corp
GECC
$83.3M
$54.5K 0.05%
10,000
– –
IVVD icon
161
Invivyd
IVVD
$238M
$51.5K 0.05%
59,000
+14,000
+31% +$17.6K
KYIVW
162
Kyivstar Group Warrant
KYIVW
$39.9M
$48.5K 0.04%
+3,000
New +$15.1K
TASK icon
163
TaskUs
TASK
$729M
$46.8K 0.04%
10,000
– –
ORGN
164
DELISTED
Origin Materials
ORGN
$45.1K 0.04%
+45,520
New +$74.1K
DOMO icon
165
CALL
Domo
DOMO
$180M
$44.4K 0.04%
+14,200
New +$47.5K
HOWL icon
166
Werewolf Therapeutics
HOWL
$47.5M
$36K 0.03%
+100,000
New +$60.9K
SVIV
167
Spring Valley Acquisition Corp IV
SVIV
$312M
$32.9K 0.03%
+3,233
New +$32.5K
HCAT icon
168
Health Catalyst
HCAT
$129M
$31.6K 0.03%
+15,880
New +$22.9K
MBVIU
169
M3-Brigade Acquisition VI Corp Units
MBVIU
$30K 0.03%
+2,927
New +$29.8K
NTIP icon
170
Network-1 Technologies
NTIP
$37.3M
$29.4K 0.03%
+20,000
New +$29.3K
OPTU
171
Optimum Communications Inc
OPTU
$401M
$29K 0.03%
+20,000
New +$24.9K
SAAQ
172
Space Asset Acquisition Corp
SAAQ
$316M
$26.6K 0.02%
+2,604
New +$26.8K
PMTR
173
Perimeter Acquisition Corp I
PMTR
$322M
$26.1K 0.02%
+2,502
New +$25.9K
EVOXU
174
Evolution Global Acquisition Corp Units
EVOXU
$20.6K 0.02%
+2,022
New +$20.6K
MCGA
175
Yorkville Acquisition Corp
MCGA
$244M
$20.6K 0.02%
+2,016
New +$20.5K
5 6
7
8 9

Similar funds

GCM
Gumshoe Capital Management New York $109M AUM
SSCM
Seven Six Capital Management New York $110M AUM 1.79% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $110M AUM
BWM
Briggs Wealth Management Glastonbury, Connecticut $110M AUM
QFMHK
Q Fund Management (Hong Kong) Hong Kong $110M AUM 1,372.85% 1-Year Est. Return
AC
Amitell Capital Singapore $109M AUM 50.64% 1-Year Est. Return
ANBOT
American National Bank of Texas Richardson, Texas $110M AUM 17.16% 1-Year Est. Return
SCA
Sensenig Capital Advisors Collegeville, Pennsylvania $109M AUM

Rangeley Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.

  • Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
  • Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
  • Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
  • Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
  • Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
  • Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
  • Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.